Spatial Heterogeneity and Peptide Availability Determine CTL Killing Efficiency In Vivo

• Thea Hogan,

  Affiliation Immune Cell Biology, MRC National Institute for Medical Research, Mill Hill, London, United Kingom

  ⨯
• Ulrich Kadolsky,

  Affiliation Department of Systems and Computational Biology, Albert Einstein College of Medicine, New York, New York, United States of America

  ⨯
• Sim Tung,

  Affiliation Immune Cell Biology, MRC National Institute for Medical Research, Mill Hill, London, United Kingom

  ⨯
• Benedict Seddon ,

  * E-mail: benedict.seddon@ucl.ac.uk (BS); andrew.yates@glasgow.ac.uk (AY)

  Affiliation Institute of Immunity and Transplantation, Division of Infection and Immunity, UCL, Royal Free Hospital, London, United Kingdom

  ⨯
• Andrew Yates

  * E-mail: benedict.seddon@ucl.ac.uk (BS); andrew.yates@glasgow.ac.uk (AY)

  Affiliations Department of Systems and Computational Biology, Albert Einstein College of Medicine, New York, New York, United States of America, Department of Microbiology and Immunology, Albert Einstein College of Medicine, New York, New York, United States of America, Institute of Infection, Immunity & Inflammation, College of Medical, Veterinary & Life Sciences, University of Glasgow, Glasgow, United Kingdom

  ⨯